Overview

Radiotherapy market is forecasted to value over CAGR of over 4% from the forecast period 2022-2028.

Improvements and further amendments in image-guided radiotherapy are propelling the market. The rising preference towards radiotherapy procedures for cancer treatment coupled with increasing usage of particle therapy for cancer diagnosis is spurring the market growth. Latest technological advancements in radiotherapy are expected to propel the market. Furthermore, rising incidences of cancer have expanded the market. According to the American Cancer Society, in 2020, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the United States. The rise in research and development activities regarding cancer treatment launched by non-government and government organizations is expected to boost the market.

The market is classified into product type, type, application, end-user and region.

Based on regions, North America dictates the market growth. Presence of prominent players and developed healthcare infrastructure is boosting the market in the region. Growing cases of cancer and favorable government policies are promoting adoption of radiotherapy, thus positively influencing the market.

Asia-Pacific region is expected to be a lucrative region for manufacturers owing to a rapidly improving healthcare infrastructure and growing per capita income in emerging economies like China, Japan and India. In addition, favorable policies launched by the governments of these countries is expected to strengthen market position in the region.

Major players included in the Radiotherapy Market:
• Accuray Incorporated
• C. R. Bard, Inc.
• Elekta
• Hitachi, LTD.
• Iba (Ion Beam Applications Sa)
• Isoray Medical, Inc.
• Mevion Medical Systems, Inc.
• Optivus Proton Therapy, Inc.
• Panacea Medical Technologies Pvt. LTD.
• P-Cure LTD.
• Provision Healthcare, LLC.
• Sumitomo Heavy Industries, LTD
• Theragenics Corporation
• Varian Medical Systems, Inc.
• Viewray Inc.
(Note: The list of the major players will be updated with the latest market scenario and trends)

Competitive Landscape:
● Varian Medical Systems in 2017, opened its centre in Jundiai, Brazil. The move will increase the access to advanced radiotherapy equipment and treatment across Brazil
● Varian Medical Systems launched an innovative treatment platform called Halcyon Treatment System. The system eases treatment delivery with increased speed and high-quality plans
● Mitsubishi Electric in 2017 decided to transfer its particle therapy systems to Hitachi

Radiotherapy Market Segmentation:

By Product Type
• External Beam Radiotherapy
o Linear Accelerators (LINAC)
• Conventional Linear Accelerators
• Stereotactic Advanced Electron/Cobalt-60 Linear Accelerators
o Gamma Knife
o Cyberknife
o Tomotherapy
o Particle Therapy Systems
• Cyclotrons
• Synchrotrons
• Synchrocyclotrons
o Conventional Cobalt-60 Teletherapy Units
• Internal Beam Radiotherapy/Brachytherapy
o Seeds
o Applicators
o Afterloaders
o Electronic Brachytherapy Products
• Systemic Radiotherapy
o Iobenguane (I-131)
o Samarium-153
o Rhenium-186
o Other Systemic Radiotherapy Products

By Type
• External Beam Radiotherapy
o Image-Guided Radiotherapy (IMRT)
o 3D Conformal Radiotherapy (3D CRT)
o Intensity-Modulated Radiotherapy (IMRT)
• Volumetric Arc Therapy (VMAT)
• Tomotherapy
o Stereotactic Therapy
o Particle Therapy (Heavy-Ion and Proton Therapy)
• Internal Beam Radiotherapy
o Low-Dose-Rate (LDR) Brachytherapy
o High-Dose-Rate (HDR) Brachytherapy
o Pulsed-Dose-Rate (PDR) Brachytherapy
• Systemic Radiotherapy
o Intravenous Radiotherapy
o Oral Radiotherapy
o Instillation Radiotherapy

By Application
• External Beam Radiation Therapy
o Prostate Cancer
o Breast Cancer
o Lung Cancer
o Head and Neck Cancer
o Colorectal Cancer
o Other Cancers
• Internal Beam Radiotherapy/Brachytherapy
o Prostate Cancer
o Gynecological Cancer
o Breast Cancer
o Cervical Cancer
o Penile Cancer
o Other Cancers

By End User
• Hospitals
• Independent Radiotherapy Centers

By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

FutureWise Key Takeaways
● Growth Prospects
● SWOT Analysis
● Key Trends
● Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on radiotherapy the market by type, by product type, by application, by end-user and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America and Middle East and Africa
• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
• Profiling of companies to evaluate their market shares, strategies, financial and core competencies

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com